Panel Archives - Loyal Conservatives

Joy Reid Stirs Controversy in CNN Panel by Defending Iran’s Nuclear Goals, Draws Sharp Critique with Comparison of LGBTQ Rights

NEW YORK – Tensions flared on CNN’s “Newsnight” Tuesday as former MSNBC host Joy Reid defended Iran’s nuclear ambitions, comparing the Iranian government’s treatment of LGBTQ individuals unfavorably to those in the United States. The heated debate opened amidst discussions on President Donald Trump’s recent authorized military strikes against Iranian nuclear facilities, stirring a broader conversation about Middle Eastern geopolitics and human rights. Reid argued that Iran’s quest for nuclear weapons is driven by a …

Shark Tank’s Kevin O’Leary Sparks Firestorm with Harsh Critique of Kamala Harris on CNN Panel

NEW YORK — A fiery discussion unfolded on CNN’s “NewsNight” program Tuesday evening, spotlighting deep divisions within the Democratic Party following their recent presidential election loss. Businessman and television personality Kevin O’Leary sparked controversy by labeling former Vice President Kamala Harris a “loser,” a term he justified by pointing to her defeat in the 2024 presidential race. The tensions surfaced as panelists debated the party’s strategy after President Joe Biden opted out of the 2024 …

Bill Maher Predicts Trump Loss in 2024 Election Despite Tight Polls, Stirs Panel Discussion on ‘Real Time’

Los Angeles — As the 2024 presidential race heats up, television host Bill Maher has made a bold prediction on his HBO show “Real Time with Bill Maher,” forecasting a defeat for former President Donald Trump. This prediction comes amidst a backdrop of national anxiety, with recent polls showing a razor-thin margin between Trump and Vice President Kamala Harris. During a recent episode, Maher confidently told panelists, including Israeli historian Yuval Noah Harari, writer Fran …

FDA Panel Overwhelmingly Supports CAR-T Therapies for Multiple Myeloma Treatment

Silver Spring, Maryland – The FDA’s Oncologic Drugs Advisory Committee discussed the risks and benefits of CAR-T therapies developed by Johnson & Johnson, Legend Biotech, Bristol Myers Squibb, and 2seventyBio for the treatment of multiple myeloma. The committee voted in support of Carvykti and Abecma as earlier lines of treatment, despite concerns about early deaths in the trials. During the meeting, experts evaluated the data from the trials, noting a higher rate of early deaths …